ロード中...

Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma

Classical Hodgkin lymphoma (cHL) is a B-cell-derived lymphoid malignancy with the most favorable prognosis among various adult malignancies. However, once it becomes refractory disease to chemotherapy or relapses after high-dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT), it...

詳細記述

保存先:
書誌詳細
出版年:Onco Targets Ther
主要な著者: Makita, Shinichi, Maruyama, Dai, Tobinai, Kensei
フォーマット: Artigo
言語:Inglês
出版事項: Dove 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7320890/
https://ncbi.nlm.nih.gov/pubmed/32606807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S193951
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!